Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythropoietin and anemia.

E M Tong1, A R Nissenson

  • 1Division of Nephrology, Department of Medicine, UCLA School of Medicine, Los Angeles, CA, USA.

Seminars in Nephrology
|March 14, 2001
PubMed
Summary

Recombinant human erythropoietin (rHuEPO) therapy significantly improves survival and quality of life for patients with chronic renal failure anemia. Further research is needed to address resistance, iron deficiency, and optimal treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to "Disparities in provision of transplant information affect access to kidney transplantation" by Kucirka et al.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

The effects of neuroticism and extraversion on cardiovascular reactivity during a mental and an emotional stress task.

International journal of psychophysiology : official journal of the International Organization of Psychophysiology·2009
Same author

The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?

Kidney international·2007
Same author

Catheter use is high even among hemodialysis patients with a fistula or graft.

Kidney international·2006

Area of Science:

  • Nephrology
  • Hematology
  • Pharmacology

Background:

  • Anemia is a common complication of chronic renal failure.
  • Recombinant human erythropoietin (rHuEPO) has emerged as a primary treatment.
  • rHuEPO therapy has demonstrated significant benefits in renal patients.

Purpose of the Study:

  • To review the impact of rHuEPO on anemia of chronic renal failure.
  • To identify areas for further research and clinical application.

Main Methods:

  • Literature review of studies on rHuEPO in renal failure.
  • Analysis of clinical outcomes and physiological understanding.

Main Results:

  • rHuEPO improves survival, reduces hospitalizations, and enhances cognitive function.
  • It has advanced the understanding of anemia and EPO physiology.
  • Subcutaneous administration offers increased efficiency.

Conclusions:

  • rHuEPO has transformed anemia treatment in renal disease.
  • Further research is required to optimize its use and overcome challenges like resistance and iron deficiency.
  • Defining EPO production sites and kidney oxygen sensing mechanisms remains crucial.

Related Experiment Videos